ReviewVirulence2025
Deciphering the immunomodulatory cross-talk: Bacterial extracellular vesicles in gut homeostasis.
Review in Virulence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Bacterial Extracellular Vesicles as Regulators of the Gut Microbiome-Circadian Axis in Inflammatory and Metabolic Diseases.Journal of microbiology and biotechnology · 2026Review
- Bacterial Extracellular Vesicles at the Crossroads of Immune Regulation and Biofilm Dynamics: Biogenesis, Comparative Analysis, and Translational Challenges.Biomolecules · 2026Review
- Article
- Probiotic-Derived Extracellular Vesicles as Potential Nano-Immunotherapeutic Platforms in IBD: A Clinician's Perspective.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Within mammalian gastrointestinal ecosystems, trillions of microorganisms generate sophisticated ecological networks through bacterial extracellular vesicles (bEVs). Emerging evidence positions these bEVs as pivotal mediators in gut homeostasis maintenance and host-microbiota crosstalk, capable of transporting bioactive cargo including virulence determinants, genetic transfer components, and host-derived defense molecules. This molecular payload enables bEVs to exert multifaceted immunomodulatory effects through: 1) Immune cell activation and differentiation. 2) Microbial community regulation. 3) Epithelial barrier reinforcement. This review systematically examines current understanding of bEV biology: First, we characterize the structural complexity and compositional diversity of bEVs across bacterial species. Second, we elucidate the molecular machinery governing bEV biogenesis and secretion pathways. Third, we analyze mechanisms underlying bEV-immune interactions through receptor-mediated signaling and cargo delivery processes. By integrating recent advances in bEV immunobiology with mechanistic insights into host-pathobiont communication networks, our framework not only clarifies current knowledge gaps but also proposes standardized methodologies for future investigations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.